What Are the Predictive Factors for Preeclampsia in Oocyte Recipients? - PREROVE
NCT03668184 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2023-04-12
Summary
The main goal is to determine which risk factors develop preeclampsia in this specific group of oocyte recipients.
Conditions
- Pregnancy
- Oocyte Donation
Interventions
- OTHER
-
preeclampsia
occurrence of pre-eclampsia
Sponsors & Collaborators
-
Rennes University Hospital
lead OTHER
Principal Investigators
-
Solène DUROS, MD · Rennes University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-02
- Primary Completion
- 2018-04-27
- Completion
- 2018-04-27
Countries
- France
Study Locations
More Related Trials
-
Preeclampsia Ratio (sFlt-1/PlGF)
NCT03289611 ·Status: COMPLETED ·Phase: NA
-
IMproved PRegnancy Outcome by Early Detection
NCT01891240 ·Status: UNKNOWN
-
Chronic Remote Ischemic Preconditioning as a Complement to Conventional Prenatal Care for Preeclampsia
NCT05564988 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Micro Array Analysis in Preeclampsia
NCT01914809 ·Status: UNKNOWN ·Phase: NA
-
sFlt-1/PlGF Ratio: Impact on the Management of Patients With Suspected Pre-eclampsia
NCT05228002 ·Status: COMPLETED ·Phase: NA
-
Immunological and Cardiovascular Phenotyping of Oocyte-donation Pregnancies
NCT04731012 ·Status: RECRUITING
-
Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers
NCT02780414 ·Status: COMPLETED
-
Non-Invasive Preeclampsia Screening and Biobank
NCT06643741 ·Status: RECRUITING
-
Preeclampsia and Circulating Biomarkers
NCT02136667 ·Status: UNKNOWN
-
At High-risk for Pre-eclampsia After Assisted Reproductive Technology
NCT05746793 ·Status: RECRUITING
-
Preeclampsia and Defective Placentation in Oocyte Donation: Importance of HLA-C and KIR
NCT07178652 ·Status: NOT_YET_RECRUITING
-
Prediction of Preeclampsia by Comprehensive Markers.
NCT03665623 ·Status: COMPLETED
-
Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
NCT02808494 ·Status: COMPLETED
-
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708 ·Status: COMPLETED
-
Evaluation of Cardiovascular Risk After Preeclampsia in General Practitioners and Patients
NCT06059937 ·Status: COMPLETED
-
Pre-Eclampsia And Growth Restriction: a Longitudinal Study
NCT02379832 ·Status: COMPLETED
-
Women's Refusal to Participate in a Randomized Trial Involving First-trimester Screening for Pre-eclampsia: Factors Associated With Refusal and Reasons for Acceptance and Refusal
NCT06322771 ·Status: COMPLETED
-
Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care
NCT05056701 ·Status: RECRUITING ·Phase: NA
-
Study of Coagulation Activation Markers and Pre Eclampsia
NCT01261351 ·Status: COMPLETED
-
Measuring Practice Pattern Changes and Clinical Utility of a Novel Test for Preeclampsia
NCT04204018 ·Status: COMPLETED ·Phase: NA
-
Development and Clinical Evaluation of an Innovative Medical Device to Predict Preterm Birth (PrediMAP)
NCT05586334 ·Status: RECRUITING ·Phase: NA
-
First-trimester Prediction of Preeclampsia
NCT02189148 ·Status: COMPLETED
-
Women's Perspective on First-trimester Preeclampsia Screening
NCT05123560 ·Status: UNKNOWN
-
Evaluation of the Efficacy of Citrulline Supplementation on the Delay of Delivery for Women Hospitalized for Pre-eclampsia (CITRUPE)
NCT02801695 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
PREdelivery Placental Biomarkers- Pregnancy and Delivery Outcome
NCT03100084 ·Status: UNKNOWN